Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

China expands export control list for drug precursor chemicals ahead of Trump-Xi summit

22 September 2026 · By · Wire by Fusion42

Published

22 September 2026

Topic

regulatory

◆ Sectors

Health

◆ Geography

China

◆ Source

Read at reuters.com →

◆ Verified

Fusion42 · 22 September 2026 · Fusion42 review

China has expanded its export control list to include two additional drug precursor chemicals, requiring export permits for sales to the US, Mexico, and Canada. This move precedes a summit between Chinese President Xi Jinping and US President Donald Trump and responds to US demands to curb fentanyl precursor exports.

This Wire brief sits within Fusion42's coverage of Health, and 10 sources have reported it between 17 Sep 2026 and 23 Sep 2026.

◆ ◆ The Wire takeaway

You face new export permit hurdles if you supply precursor chemicals linked to opioids in China. This tightens market access and could open gaps for alternative suppliers outside China.

◆ Coverage

10 sources · first reported 17 Sep 2026 · latest 23 Sep 2026

◆ Related on Wire

◆ Topics

Healthchinaexport-controldrug-precursorsus-china-relationsopioid-crisis